Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain
Conclusion: Combined impedance-pH monitoring identifies different subtypes of NCCP patients who can receive tailored management. Targeted therapy with PPIs and/or citalopram offers complete symptom relief in the great majority of them.
Source: European Journal of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Original Articles: Gastro-esophageal Disorders Source Type: research
More News: Acid Reflux | Celexa | Citalopram | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Pain | Pain Management | Proton Pump Inhibitors PPIs | Study